Hokkaido University Collaborates with BostonGene on Precision Oncology
BostonGene has announced an expanded strategic research collaboration with Hokkaido University aimed at advancing precision oncology. This multi-year initiative will focus on generating clinically relevant data to support the development of precision therapies to improve cancer patient outcomes in Japan.
TOKYO & WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced the expanded strategic research collaboration with Hokkaido University. This multi-year initiative is designed to produce actionable, high-quality, clinically relevant data that support the development of precision therapies and ultimately improve outcomes for cancer patients in Japan. In collaboration with Hokkaido University, BostonGene will conduct n